TEVA ▲ +3.2% - Teva Pharmaceutical Industries Limited $TEVA - Teva Announces U.S. Food and Drug Administration (FDA) Approval of WELTRUZA™ (Olanzapine) For Extended-Release Injectable Suspension, as the First and Only Once-Monthly Subcutaneous Injectable Olanzapine for Adults with Schizophrenia 09-OCT-2026 07:00 AM ET